# FDA EIR - Apnar Pharma LLP - May 14, 2021

Source: https://www.globalkeysolutions.net/records/eir/apnar-pharma-llp/0a8c943c-b007-49f8-b2a2-0d28915d7902

> FDA EIR for Apnar Pharma LLP on May 14, 2021. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Apnar Pharma LLP
- Inspection Date: 2021-05-14
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/monika-borkowska/4dedee7d-7b93-4f1b-be3b-17ab41e5c0ff)
- [recipient](https://www.globalkeysolutions.net/people/mahender-korapati/6f65a44c-625d-474e-bebf-bb8b389fbc61)
- [company_representative](https://www.globalkeysolutions.net/people/thirupathi-dongala/9e1a9fc1-e60f-478f-a7d5-be570e62215a)
- [company_representative](https://www.globalkeysolutions.net/people/palakurthi-ashok-kumar/ddecf40b-4106-4436-9f9b-a59edfc4e488)
- [company_representative](https://www.globalkeysolutions.net/people/sree-ranga-aravapalli/dfe86516-3344-4a8b-a625-5efb9dc17c18)

Company: https://www.globalkeysolutions.net/companies/apnar-pharma-llp/97e27879-d20b-4281-b876-7dbab65dc29d

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02